MusclePharm Corp
company.status.inactiveCIK 1415684fmd_1DH3KQG57NVX7F1JVPTYDM25TEManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Mar 31, 2022, 49 periods
Latest annual · FY2021
Millions- Total revenues
- 50
- Gross profit
- 5
- Operating income
- (9)
- Net income
- (13)
- Free cash flow
- (8)
Latest quarter · Q1 FY2022
Millions- Total revenues
- 13
- Gross profit
- 2
- Operating income
- (2)
- Net income
- (6)
- Free cash flow
- (6)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- -17.2%
- Revenue, 5 yearsFY2016 to FY2021
- -17.7%
- Net income, 5 yearsFY2016 to FY2021
- n/m
MusclePharm Corp financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $50 million | $64.4 million | -22.3% | 10-K 2022-04-15 · proof |
| Gross profit | $5.4 million | $19.6 million | -72.6% | 10-K 2022-04-15 · proof |
| Operating income | -$8.9 million | $2.6 million | -442.5% | 10-K 2022-04-15 · proof |
| Net income | -$12.9 million | $3.2 million | -504% | 10-K 2022-04-15 · proof |
| Cash from operating activities | -$8 million | -$868,000 | 10-K 2022-04-15 · proof | |
| Free cash flow | -$8 million | -$872,000 | 10-K 2022-04-15 · proof | |
| Total assets | $10.7 million | $13 million | -17.5% | 10-Q 2022-05-16 · proof |
| Total liabilities | $42.9 million | $37.4 million | +14.7% | 10-Q 2022-05-16 · proof |
| Cash and cash equivalents | $1.2 million | $2 million | -38.9% | 10-K 2022-04-15 · proof |
| Total debt | $33.4 million | $11.8 million | +181.6% | 10-Q 2022-05-16 · proof |
- What was MusclePharm Corp's revenue in fiscal 2021?
- MusclePharm Corp reported revenue of $50 million for fiscal 2021 (the year ended Dec 31, 2021), against $64.4 million the year before (-22.3%). Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What was MusclePharm Corp's gross profit in fiscal 2021?
- MusclePharm Corp reported gross profit of $5.4 million for fiscal 2021 (the year ended Dec 31, 2021), against $19.6 million the year before (-72.6%). Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What was MusclePharm Corp's operating income in fiscal 2021?
- MusclePharm Corp reported operating income of -$8.9 million for fiscal 2021 (the year ended Dec 31, 2021), against $2.6 million the year before (-442.5%). Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What was MusclePharm Corp's net income in fiscal 2021?
- MusclePharm Corp reported net income of -$12.9 million for fiscal 2021 (the year ended Dec 31, 2021), against $3.2 million the year before (-504%). Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What was MusclePharm Corp's cash from operating activities in fiscal 2021?
- MusclePharm Corp reported cash from operating activities of -$8 million for fiscal 2021 (the year ended Dec 31, 2021), against -$868,000 the year before. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What was MusclePharm Corp's free cash flow in fiscal 2021?
- MusclePharm Corp reported free cash flow of -$8 million for fiscal 2021 (the year ended Dec 31, 2021), against -$872,000 the year before. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What are MusclePharm Corp's total assets?
- As of Dec 31, 2021, MusclePharm Corp reported total assets of $10.7 million, against $13 million a year earlier (-17.5%). Source: the 10-Q filed with the SEC on May 16, 2022 (restated). SEC
- What are MusclePharm Corp's total liabilities?
- As of Dec 31, 2021, MusclePharm Corp reported total liabilities of $42.9 million, against $37.4 million a year earlier (+14.7%). Source: the 10-Q filed with the SEC on May 16, 2022 (restated). SEC
- What are MusclePharm Corp's cash and cash equivalents?
- As of Dec 31, 2021, MusclePharm Corp reported cash and cash equivalents of $1.2 million, against $2 million a year earlier (-38.9%). Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What is MusclePharm Corp's total debt?
- As of Dec 31, 2021, MusclePharm Corp reported total debt of $33.4 million, against $11.8 million a year earlier (+181.6%). Source: the 10-Q filed with the SEC on May 16, 2022 (restated). SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1415684&period_type=annual&limit=5"Information only, not investment advice.